Search for: "Mylan Pharmaceuticals v. FDA"
Results 201 - 220
of 233
Sorted by Relevance
|
Sort by Date
11 Mar 2019, 7:08 pm
In the 2017 Phigenix v. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
1 Feb 2016, 10:43 am
Atlas Powder Co. v. [read post]
12 Mar 2017, 9:28 am
On the 26 April 2017, the US Supreme Court will hear arguments on this issue in Sandoz v Amgen. [read post]
23 Oct 2008, 9:03 am
., v. [read post]
19 Feb 2016, 11:57 am
Brown v. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
15 Apr 2011, 6:02 am
Mylan Pharmaceuticals, Inc., 2009 WL 7115134, at *2 (N.D. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO:… [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
13 Mar 2024, 7:24 pm
” (see also Hoechst-Roussel Pharms., Inc. v. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
7 Mar 2022, 2:07 pm
James Landolt v. [read post]
28 Jun 2016, 6:41 am
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
